Ara
Toplam kayıt 2, listelenen: 1-2
PD-1 and PD-L2 expression predict relapse risk and poor survival in patients with stage III colorectal cancer
(Springer Science and Business Media B.V., 2021)
Background: Immune responses have long been an area of interest in cancer research. In this study, the effects of programmed cell death-1 (PD-1) and its ligand (PD-L2) on the prognosis of colorectal cancer (CRC) were ...
Platelet-lymphocyte ratio predicts poor prognosis in stage II / III colon and rectum cancer
(2022)
Objective: There is an increasing number of studies in the literature reporting that serum platelet/lymphocyte ratio (PLR) can provide useful prognostic data for various cancers. In the present study, the effects of ...